262 related articles for article (PubMed ID: 33377205)
1. Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies.
Gao Y; Zhou J; Li J
Cancer Sci; 2021 Mar; 112(3):962-969. PubMed ID: 33377205
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
Trono P; Ottavi F; Rosano' L
Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
[TBL] [Abstract][Full Text] [Related]
3. Collagen recognition and transmembrane signalling by discoidin domain receptors.
Carafoli F; Hohenester E
Biochim Biophys Acta; 2013 Oct; 1834(10):2187-94. PubMed ID: 23128141
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
Leitinger B
J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
[TBL] [Abstract][Full Text] [Related]
5. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
6. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
[TBL] [Abstract][Full Text] [Related]
7. Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship.
Shenoy GP; Pal R; Purwarga Matada GS; Singh E; Raghavendra NM; Dhiwar PS
Bioorg Chem; 2023 Jan; 130():106215. PubMed ID: 36384067
[TBL] [Abstract][Full Text] [Related]
8. Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration.
Fowler AJ; Hebron M; Missner AA; Wang R; Gao X; Kurd-Misto BT; Liu X; Moussa CE
Drugs R D; 2019 Jun; 19(2):149-166. PubMed ID: 30919310
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation.
Denny WA; Flanagan JU
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827669
[TBL] [Abstract][Full Text] [Related]
10. A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril.
Orgel JPRO; Madhurapantula RS
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118478. PubMed ID: 31004686
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
12. Using synthetic peptides and recombinant collagen to understand DDR-collagen interactions.
Chen EA; Lin YS
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118458. PubMed ID: 30880148
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor functions in physiological and pathological conditions.
Leitinger B
Int Rev Cell Mol Biol; 2014; 310():39-87. PubMed ID: 24725424
[TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
[TBL] [Abstract][Full Text] [Related]
16. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
[TBL] [Abstract][Full Text] [Related]
17. Discoidin Domain Receptor 2: A New Target in Cancer.
Xu X; Yu T; Wang Z
Oncol Res Treat; 2022; 45(4):205-215. PubMed ID: 35073544
[TBL] [Abstract][Full Text] [Related]
18. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 is activated independently of beta(1) integrin.
Vogel W; Brakebusch C; Fässler R; Alves F; Ruggiero F; Pawson T
J Biol Chem; 2000 Feb; 275(8):5779-84. PubMed ID: 10681566
[TBL] [Abstract][Full Text] [Related]
20. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
Leitinger B; Steplewski A; Fertala A
J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
